Dexmedetomidine vs propofol-remifentanil intravenous anesthesia with spontaneous ventilation for airway foreign body removal in children: a prospective evaluation

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900026107

Enrollment

Unknown

Registered

2019-09-21

Start date

2019-10-01

Completion date

Unknown

Last updated

2019-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Airway foreign body

Interventions

Group 2:Dexmedetomidine

Group 1:propofol and remifentanil

Eligibility

Sex/Gender

All

Age

1 Years to 5 Years

Inclusion criteria

Inclusion criteria: 1. Patients scheduled for airway foreign body removal; 2. Aged 10–60 months; 3. American Society of Anesthesiologists (ASA) grades I-II.

Exclusion criteria

Exclusion criteria: 1. Patients with a known allergy to the study drugs; 2. Children with congenital disease, asthma, preexisting pneumothorax.

Design outcomes

Primary

Measure	Time frame
HR;MAP;SpO2;ETCO2;ETCO2;	—

Secondary

Measure	Time frame
Intraoperative body movement,;Breath holding;Pperioperative hypoxemia;Bronchospasm;Laryngospasm;Tracheal intubation;????;Coughing;	—

Countries

China

Contacts

Public ContactYe Yuan

The First Hospital of Jilin University

yeyuan1225@sina.com+86 13604430557

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026